142 related articles for article (PubMed ID: 12702145)
41. No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma.
Waldmann V; Wacker J; Deichmann M; Näher H
Dermatology; 2000; 201(1):6-9. PubMed ID: 10971051
[TBL] [Abstract][Full Text] [Related]
42. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
43. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract][Full Text] [Related]
44. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
45. [Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients].
Leinung S; Schönfelder A; Schönfelder M
Zentralbl Chir; 1998; 123(5):520-4. PubMed ID: 22462221
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Brunsvig PF; Flatmark K; Aamdal S; Høifødt H; Le H; Jakobsen E; Sandstad B; Fodstad O
Lung Cancer; 2008 Aug; 61(2):170-6. PubMed ID: 18261824
[TBL] [Abstract][Full Text] [Related]
47. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K
Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327
[TBL] [Abstract][Full Text] [Related]
48. Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies.
Weihrauch MR; Skibowski E; Draube A; Geller A; Tesch H; Diehl V; Bohlen H
Clin Exp Metastasis; 2002; 19(7):617-21. PubMed ID: 12498391
[TBL] [Abstract][Full Text] [Related]
49. Metastatic melanoma in the marrow: a black and white diagnosis.
Bhandari S; Jack F; Hussain K; Bell A
Br J Haematol; 2009 Oct; 147(1):1. PubMed ID: 19298247
[No Abstract] [Full Text] [Related]
50. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
Braun S; Pantel K
Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
[TBL] [Abstract][Full Text] [Related]
51. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
[TBL] [Abstract][Full Text] [Related]
53. The detection of isolated tumor cells in bone marrow comparing bright-field immunocytochemistry and multicolor immunofluorescence.
Krag DN; Kusminsky R; Manna E; Ambaye A; Weaver DL; Harlow SP; Covelli M; Stanley MA; McCahill L; Ittleman F; Leavitt B; Krag M
Ann Surg Oncol; 2005 Sep; 12(9):753-60. PubMed ID: 16079954
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative touch imprint cytological analysis of sentinel lymph nodes for the presence of metastases in malignant melanoma.
Tamiolakis D; Venizelos J; Jivanakis T; Antoniou C; Economou C; Tsiminikakis N; Georgiou G; Alexiadis G; Costopoulou A
Minerva Med; 2008 Feb; 99(1):15-21. PubMed ID: 18299693
[TBL] [Abstract][Full Text] [Related]
55. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
56. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Kienle P; Weitz J; Klaes R; Koch M; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
Arch Surg; 2000 Feb; 135(2):213-8. PubMed ID: 10668884
[TBL] [Abstract][Full Text] [Related]
57. The detection of tyrosinase-specific mRNA in bone marrow is not more sensitive than in blood for the demonstration of micrometastatic melanoma.
Waldmann V; Deichmann M; Bock M; Jäckel A; Näher H
Br J Dermatol; 1999 Jun; 140(6):1060-4. PubMed ID: 10354071
[TBL] [Abstract][Full Text] [Related]
58. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
[TBL] [Abstract][Full Text] [Related]
59. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
Wu Y; Yao LQ; Cheng J; Tian H
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
[TBL] [Abstract][Full Text] [Related]
60. A monoclonal antibody specific for cells of the melanocyte lineage.
Vennegoor C; Hageman P; Van Nouhuijs H; Ruiter DJ; Calafat J; Ringens PJ; Rümke P
Am J Pathol; 1988 Jan; 130(1):179-92. PubMed ID: 3276209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
